Frameworks for Digital Advertising
Standards in Medicine.

Italy · Advertising framework

Outdoor and place-based advertising for diagnostic tests and services in Italy

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Separate diagnostic products from diagnostic services

Legal requirement — paraphrased

IVDR Article 7 prohibits misleading claims for an in vitro diagnostic device. Describe the intended purpose, users and limitations consistently with its conformity documentation. An advertisement for a laboratory consultation also needs the applicable local provider review; the IVDR does not by itself authorise a medical service.

Sources: EU In Vitro Diagnostic Medical Devices Regulation 2017/746

Device advertising has an Italian authorisation layer

Regulator guidance

Applies when: The advertised offer is a device or IVD; software follows this route only if classified accordingly.

Check the national rules for DM and IVD public advertising, the product’s intended user and the applicable ministerial exemptions. Where authorisation is required, approval relates to the message and media. EU conformity alone does not replace this national advertising review.

Sources: Licenze di pubblicità sanitaria; 2025 guidelines for advertising DM, IVD and PMC

Channel rules

Check the complete consumer-facing message

Regulator guidance

The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.

Sources: EU Unfair Commercial Practices Directive 2005/29/EC

Check public exposure and legibility

Editorial recommendation

Review the actual viewing distance, dwell time and location. Treat the placement as public-facing and establish whether the required information can fit legibly; do not shorten mandatory wording without a supported exception.

Campaign workflow

Diagnostics & Health Testing: prepare the review

Editorial recommendation

Separate a test kit, laboratory service, screening package and medical interpretation. State the intended population and explain the limits of a positive or negative result. Review both product rules and provider rules when a device is bundled with a clinical service.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Separate a test kit, laboratory service, screening package and medical interpretation.
  • State the intended population and explain the limits of a positive or negative result.
  • Review both product rules and provider rules when a device is bundled with a clinical service.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • The Gazette text of the 2023 healthcare-promotion amendment and the Ministry OTC/SOP application procedure are documented. A final consolidated-law check, regional provider conditions and exact authorised social-media functions remain necessary. AGCOM disclosure and registration thresholds do not replace healthcare advertising authorisation.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

Advertising diagnostic tests and services on outdoor and place-based displays in Italy requires a distinction between the test product, the laboratory service and the interpretation of the result. Use this framework to review those layers and the limits of the advertised outcome.

A poster, digital screen and waiting-room display raise different execution questions. Assess viewing distance, display format and location together, preserving the specific restrictions that can apply inside healthcare or retail premises.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. Italian medicine, device and medical-information baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. EU In Vitro Diagnostic Medical Devices Regulation 2017/746

    European Union · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  2. Licenze di pubblicità sanitaria

    Ministry of Health · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  3. 2025 guidelines for advertising DM, IVD and PMC

    Ministry of Health · regulator guidance · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  4. EU Unfair Commercial Practices Directive 2005/29/EC

    European Union · legislation · checked 2026-10-24

    EU framework implemented through national law; sector rules and local implementation also apply.

From framework to action

Local expertise in Italy

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Italy.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in Italy

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.